Fibroblast migration was assessed using a “scratch wound” assay, as described previously (13). Fibroblasts were seeded on a six-well plate to a final concentration of 5 × 105 cells/ml. Once confluent, a cell-free area was created with a pipette in each well. Cells were then treated with either TGF-β1 (10 ng/ml) or TGF-β1 along with recombinant hsdc2 (0.5 μg/ml) for 24 hours. Wound closure and fibroblast migration was evaluated at 0, 4, 8, 12, 16, 20, and 24 hours after treatment.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.